Advertisement
Screener

Gartner, Inc. (IT) Proceeds from Lines of Credit

3.2 / 5 stars · 76/120 Roast Me

Gartner, Inc. Proceeds from Lines of Credit

Gartner, Inc. (IT) reported Proceeds from Lines of Credit of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromLinesOfCredit · last filed 2026-02-12

  • Gartner, Inc. proceeds from lines of credit for the quarter ending 2025-12-31 was $0.00.
  • Gartner, Inc. proceeds from lines of credit for the quarter ending 2025-09-30 was $0.00.
  • Gartner, Inc. proceeds from lines of credit for the quarter ending 2025-06-30 was $0.00.
  • Gartner, Inc. proceeds from lines of credit for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
  • Gartner, Inc. proceeds from lines of credit for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • Gartner, Inc. proceeds from lines of credit for fiscal 2024 was $274.40M.
  • Gartner, Inc. proceeds from lines of credit for fiscal 2023 was $0.00.
  • Gartner, Inc. proceeds from lines of credit for fiscal 2022 was $0.00.
Period endProceeds from Lines of Credit 3 monthProceeds from Lines of Credit 6 monthProceeds from Lines of Credit 9 monthProceeds from Lines of Credit 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$0.00
derived: sum of 2 quarters · filed 2026-02-12
$0.00
derived: sum of 3 quarters · filed 2026-02-12
$0.00
10-K · filed 2026-02-12
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$0.00
derived: sum of 2 quarters · filed 2025-11-04
$0.00
10-Q · filed 2025-11-04
$0.00
derived: sum of 4 quarters · filed 2026-02-12
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$0.00
10-Q · filed 2025-08-05
$0.00
derived: sum of 3 quarters · filed 2026-02-12
$0.00
derived: sum of 4 quarters · filed 2026-02-12
2025-03-31$0.00
10-Q · filed 2025-05-06
$0.00
derived: sum of 2 quarters · filed 2026-02-12
$0.00
derived: sum of 3 quarters · filed 2026-02-12
$0.00
derived: sum of 4 quarters · filed 2026-02-12
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$0.00
derived: sum of 2 quarters · filed 2026-02-12
$0.00
derived: sum of 3 quarters · filed 2026-02-12
$274.40M
10-K · filed 2026-02-12
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$0.00
derived: sum of 2 quarters · filed 2025-11-04
$274.40M
10-Q · filed 2025-11-04
$274.40M
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$274.40M
10-Q · filed 2025-08-05
$274.40M
derived: sum of 3 quarters · filed 2026-02-12
$274.40M
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31$274.40M
10-Q · filed 2025-05-06
$274.40M
derived: sum of 2 quarters · filed 2026-02-12
$274.40M
derived: sum of 3 quarters · filed 2026-02-12
$274.40M
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$0.00
derived: sum of 2 quarters · filed 2026-02-12
$0.00
derived: sum of 3 quarters · filed 2026-02-12
$0.00
10-K · filed 2026-02-12
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
$0.00
derived: sum of 2 quarters · filed 2024-11-05
$0.00
10-Q · filed 2024-11-05
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
$0.00
10-Q · filed 2024-07-30
2023-03-31$0.00
10-Q · filed 2024-04-30
2022-12-31$0.00
10-K · filed 2025-02-13
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$0.00
derived: sum of 2 quarters · filed 2023-02-16
$0.00
derived: sum of 3 quarters · filed 2023-02-16
$0.00
10-K · filed 2023-02-16
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
$0.00
derived: sum of 2 quarters · filed 2021-11-02
$0.00
10-Q · filed 2021-11-02
$5.00M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$0.00
10-Q · filed 2021-08-03
$5.00M
derived: sum of 3 quarters · filed 2023-02-16
$5.00M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$0.00
10-Q · filed 2021-05-04
$5.00M
derived: sum of 2 quarters · filed 2023-02-16
$5.00M
derived: sum of 3 quarters · filed 2023-02-16
$305.00M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$5.00M
derived: sum of 2 quarters · filed 2023-02-16
$305.00M
derived: sum of 3 quarters · filed 2023-02-16
$332.00M
10-K · filed 2023-02-16
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
$300.00M
derived: sum of 2 quarters · filed 2021-11-02
$327.00M
10-Q · filed 2021-11-02
$355.00M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30$300.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$327.00M
10-Q · filed 2021-08-03
$355.00M
derived: sum of 3 quarters · filed 2022-02-23
$383.00M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31$27.00M
10-Q · filed 2021-05-04
$55.00M
derived: sum of 2 quarters · filed 2022-02-23
$83.00M
derived: sum of 3 quarters · filed 2022-02-23
2019-12-31$28.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
$56.00M
derived: sum of 2 quarters · filed 2022-02-23
$309.00M
10-K · filed 2022-02-23
2019-09-30$28.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03
$281.00M
10-Q · filed 2020-11-03
2019-06-30$253.00M
10-Q · filed 2020-08-04
2018-12-31$248.00M
10-K · filed 2021-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Evolent Health, Inc. (EVH)United States$0.397B-1.21
FRANKLIN COVEY CO (FC)United States$0.195B123.76